HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹72 Cr | ₹128 Cr | ₹24 Cr | ₹80 Cr | ₹78 Cr |
What is the latest Long Term Provisions ratio of HIKAL ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹78 Cr |
How is Long Term Provisions of HIKAL Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | -44.07 | |
| Mar2024 | ₹128 Cr | 429.23 | |
| Mar2023 | ₹24 Cr | -69.56 | |
| Mar2022 | ₹80 Cr | 2.11 | |
| Mar2021 | ₹78 Cr | - | |
Compare Long Term Provisions of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,274.3 Cr | -5.7% | -15.6% | -49.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -5.7% |
-15.6% |
-49.9% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses